… Arsham Sheybani, MD, Department of Ophthalmology and Visual Sciences, Washington
University School of Medicine in Saint Louis, 660 South Euclid Avenue, Campus Box 8096 …

Purpose: The purpose of this study was to describe the fluidics of a novel non-valved glaucoma
implant designed to prevent hypotony and compare the fluidics of this device with two …

Purpose: To evaluate the intraocular pressure (IOP) lowering effect of the XEN140 microfistula
gel stent implant for the surgical treatment of open-angle glaucoma. Patients and Methods…

… Author links open overlay panel Arsham Sheybani MD , Markus Lenzhofer MD , Melchior …
Sheybani has received travel reimbursement from Aquesys, Inc. Dr. Ahmed is a paid …

A systematic literature review was performed evaluating articles examining the effects of
pseudoexfoliation syndrome (PEX) and glaucoma (PEXG) on the cornea with a focus on the …

Intraoperative management of posterior capsular rupture : Current Opinion in
Ophthalmology Intraoperative management of posterior capsular rupture : Current Opinion …

Importance The transscleral XEN Glaucoma Gel Microstent (XEN‐GGM, Allergan Plc.,
Parsippany, New Jersey) is implanted by a minimally invasive ab interno technique. Background …

… Author links open overlay panel ARSHAM SHEYBANI a , VANESSA VERA b , DAVINDER
S. … Louis Human research Protection Office (Arsham Sheybani); and Wills Eye Hospital IRB (…

Glaucoma is a chronic, debilitating disease and a leading cause of global blindness. Despite
treatment efforts, 10% of patients demonstrate loss of vision. In the US, > 80% of glaucoma …

In 2018, the American Glaucoma Society (AGS), the world, s largest professional society of
glaucoma subspecialists, convened a 12-member task force of experts to craft a position …